2025³â 07¿ù 05ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Business

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

ATLAS Welcomes Strengthened Commitment to Increased Shareholder Returns from SES Board

ATLAS supports the decision to modernize Board
´º½ºÀÏÀÚ: 2025-03-31

LONDON -- ATLAS Infrastructure (“ATLAS”) is a specialist listed infrastructure investor managing funds on behalf of long-term infrastructure clients. ATLAS’s actively managed accounts currently hold in aggregate a greater than 10% voting interest and 12.5% economic interest in SES S.A (“SES” or the “Company”).

ATLAS supports the decision from the SES Board of Directors (“the Board”) to further strengthen Company governance through a modernisation of the Board structure and composition. Introducing further capital markets experience into a reduced Board of 9 increases alignment of stakeholder interests. ATLAS looks forward to continuing its engagement with the Board, the Nomination Committee and other Significant Stakeholders to assist with finding the best possible candidate during the upcoming selection process.

Further, ATLAS welcomes the decision by the Board to endorse Shareholder Resolution 22 (“Resolution on Capital Return to Shareholders”) at the 2025 Annual General Meeting. The Board’s strengthened commitment to prioritize the return to shareholders of at least a majority of future exceptional cashflows will enhance capital allocation discipline and help reduce the company’s discount to its intrinsic value.

“We see SES as a critical component of Europe’s Sovereign secure communications infrastructure and well positioned to capitalise on the significant growth in demand for digital infrastructure services and capabilities. We believe that SES is currently trading at a substantial discount to fair value, at least partly as a result of concerns over capital allocation. We strongly encourage all shareholders to support Resolution 22 which strengthens the capital return imperative while maintaining Management’s flexibility to capitalize on current growth opportunities.”

- Rod Chisholm, Partner

ATLAS looks forward to continuing its engagement with the Board, Management and other Significant Shareholders on this topic.



 Àüü´º½º¸ñ·ÏÀ¸·Î

HistoSonics Wins First Insurance for Non-Invasive Liver Tumor Treatment with BCBS Michigan
Andersen Consulting Enhances Business Transformation Capabilities With Addition of The Clearing
ZEDRA Appoints Dean Blackburn as CEO
ExaGrid Expands Cohesity Partnership With New Integrations, Enabling Seamless Backup for NetBackup and DataProtect Users
Bentley Systems, Enactus Launch 2025 iTwin4Good Challenge Amid Global Infrastructure Workforce Shortage
TH Global Capital Wins ¡®Boutique Investment Bank of The Year¡¯ for 3rd Time at The 16th International M&A Awards
MSCI Announces Results of the MSCI 2025 Market Classification Review

 

Expensify Expands Global Support for Company Cards, Languages, Billing...
¡®TH Growth Strategy + Deal¡¯ to Drive Sustained Value Creation for Cl...
Celonis Named a Leader for Sixth Consecutive Year and Star Performer i...
Lenovo Ranks 8th in the Gartner¢ç Supply Chain Top 25 for 2025
Auramet Closes $350 Million Syndicated Revolving Credit Facility to Su...
Bruce Markets Announces New Round of Strategic Investment Backed by In...
VeriSilicon Expands DSP Portfolio with Silicon-Proven ZSP5000 Vision C...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..